2022年，繼續(xù)做好常態(tài)化疫情防控

China will continue its routine COVID-19 control measures this year, with a focus on rolling out targeted and scientific measures to minimize their impact on normal production and life, as well as accelerating research into vaccines and medicines, according to the Government Work Report released on Saturday.

根據(jù)3月5日發(fā)布的政府工作報(bào)告，2022年，中國將繼續(xù)做好常態(tài)化疫情防控，落實(shí)科學(xué)精準(zhǔn)防控措施，降低對(duì)正常生產(chǎn)生活的影響，并加快疫苗和特效藥物研發(fā)。

The country will stick to its strategy of preventing imported infections and domestic flare-ups while refining its virus containment measures by stepping up the capabilities of port cities, intensifying studies into virus mutations and continuing the mass vaccination campaign.
中國將堅(jiān)持外防輸入、內(nèi)防反彈，不斷優(yōu)化完善防控措施，加強(qiáng)口岸城市疫情防控，加大對(duì)病毒變異的研究，持續(xù)做好疫苗接種工作。

Last year, China consolidated outcomes achieved through its effective COVID-19 response and fully vaccinated over 85 percent of its population, according to the report, which Premier Li Keqiang delivered at the opening of the fifth session of the 13th National People's Congress.
根據(jù)李克強(qiáng)總理在十三屆全國人大五次會(huì)議上作的政府工作報(bào)告，2021年，中國通過有效的防疫措施和85%的疫苗全程接種覆蓋率鞏固了所取得的抗疫成果。